Hey Davybabyk,
In case you are looking to do more research I’d be very interested in your assessment of auto versus allo CAR Ts.
Specifically in terms of our Azer-cel and why it’s better. I understand allogeneic has advantages over auto and that our Azer-cel is not showing any toxicity at this early stage. Why is that and is this the new direction of CAR T therapy?
Much appreciated and looking forward to your response.
Cheers
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1767 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 1177 | 1 |
View Market Depth
| Last trade - 09.19am 15/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable